|
BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 28, 2022 /PRNewswire/ - - Aurealis Therapeutics, a synthetic biology company developing groundbreaking four - in - one cell and gene therapies and Xbiome, an AI - based microbiome drug development company, today announced that ...
Adnkronos
-
28-1-2022
|
|